{"title":"人乳头瘤病毒疫苗接种中的道德困境——重访群体效应的作用。","authors":"Matti Lehtinen, Ville N Pimenoff","doi":"10.2807/1560-7917.ES.2021.26.50.2101154","DOIUrl":null,"url":null,"abstract":"In this Eurosurveillance issue, two articles by Colzani et al. [1] and Ortu et al. [2], raise the question of who should be prioritised in vaccination policy when there is a temporary global shortage of vaccines. These articles on human papillomavirus (HPV) are a reminder that discussions pertaining to vaccination policies are not confined to coronavirus disease (COVID-19). Nonetheless, lessons learnt from the establishment of HPV vaccination are generalisable and valuable for the implementation and monitoring of most vaccination programmes, including those against COVID-19, worldwide.","PeriodicalId":520613,"journal":{"name":"Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728494/pdf/","citationCount":"3","resultStr":"{\"title\":\"Moral dilemma(s) in human papillomavirus vaccination - revisiting the role of the herd effect.\",\"authors\":\"Matti Lehtinen, Ville N Pimenoff\",\"doi\":\"10.2807/1560-7917.ES.2021.26.50.2101154\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this Eurosurveillance issue, two articles by Colzani et al. [1] and Ortu et al. [2], raise the question of who should be prioritised in vaccination policy when there is a temporary global shortage of vaccines. These articles on human papillomavirus (HPV) are a reminder that discussions pertaining to vaccination policies are not confined to coronavirus disease (COVID-19). Nonetheless, lessons learnt from the establishment of HPV vaccination are generalisable and valuable for the implementation and monitoring of most vaccination programmes, including those against COVID-19, worldwide.\",\"PeriodicalId\":520613,\"journal\":{\"name\":\"Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728494/pdf/\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2807/1560-7917.ES.2021.26.50.2101154\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2807/1560-7917.ES.2021.26.50.2101154","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Moral dilemma(s) in human papillomavirus vaccination - revisiting the role of the herd effect.
In this Eurosurveillance issue, two articles by Colzani et al. [1] and Ortu et al. [2], raise the question of who should be prioritised in vaccination policy when there is a temporary global shortage of vaccines. These articles on human papillomavirus (HPV) are a reminder that discussions pertaining to vaccination policies are not confined to coronavirus disease (COVID-19). Nonetheless, lessons learnt from the establishment of HPV vaccination are generalisable and valuable for the implementation and monitoring of most vaccination programmes, including those against COVID-19, worldwide.